The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So Jeepperone, the trade name is Exua uh is uh what class? Target SSRI, I think. And it only targets the serotonin receptors in specific parts of the brain as opposed to just like you're going to get it all. And so it has seemingly no more probability to reduce sex drive or alter consumption of food patterns than a placebo.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.